Given that the decision Third dose of COVID-19 vaccine for all adults Will be taken on scientific need basis, the government said on Thursday, adding that emerging knowledge on the subject is subject to its active consideration.
International travelers from 82 countries to be fully vaccinated permission quarantine free entry From February 14, the Ministry of Health and Family Welfare said on Thursday.
you can track coronavirus Cases, deaths and testing rates at the national and state levels Here, a list of state helpline number also available.
here are the updates,
National
WHO Chief Scientist: The pandemic is not over yet, as more forms are expected
World Health Organization chief scientist Soumya Swaminathan said on Friday that the world is not yet at the end of the COVID-19 pandemic as there will be more coronavirus variants.
“We have seen the virus evolve, mutate … so we know there will be more types, more forms of concern, so we are not at the end of the pandemic,” Ms Swaminathan told reporters in South Africa. , where she was accompanied by WHO Director-General Tedros Adhanom Ghebreyesus on a tour of vaccine manufacturing facilities. -Reuters
National
58,077 new cases registered in India, 657 deaths
India saw a one-day increase of 58,077 coronavirus infections, taking the number of cases to 4,25,36,137, while the active cases declined to 6,97,802, according to data updated by the Union Health Ministry on Friday.
For the last five consecutive days, daily COVID-19 cases are being recorded below one lakh.
The death toll has risen to 5,07,177 with 657 deaths reported daily, data updated at 8 am.
The health ministry said active cases comprise 1.64% of the total infections, while the national recovery rate has further improved.
The active COVID-19 caseload has registered a decrease of 92,987 cases in a span of 24 hours.
According to the Health Ministry, the daily positivity rate has been recorded at 3.89% while the weekly positivity rate has been recorded at 5.76%. -PTI
International
Novavax says protein vaccine is in the works for kids under 12
Novavax announced Thursday that its COVID-19 vaccine has been shown to be safe and effective in a study of 12 to 17-year-olds.
Novavax makes a protein-based vaccine – a different type than the most widely used shots – that is a late addition to the COVID-19 arsenal.
Its shots have been approved for use in adults by regulators in the UK, Europe and elsewhere and the World Health Organization, and are being reviewed by the US Food and Drug Administration. -ap
Play
Indian Open cancelled, China Open postponed on European tour
The Indian Open was canceled and the China Open postponed as pandemic-related restrictions were causing problems on the European tour.
The Indian Open was postponed from its original scheduled date of February 17 -20, but will no longer take place in 2022 at all. Tour officials said on Thursday that the event is expected to return next year.
The China Open was scheduled for April 28 to May 1, but will now take place either later in 2022 or at the start of the 2023 season, the tour said, “due to ongoing restrictions” related to COVID-19. -ap
Maharashtra
As COVID-19 cases drop, primary schools in Aurangabad city to reopen
With the number of daily coronavirus cases falling to 125, the civic body in Maharashtra’s Aurangabad city has decided to reopen primary schools from February 14.
On Thursday, the city recorded 125 new coronavirus infections, which is significantly less than 298 on February 4. -PTI
Gujarat
Night curfew reduced in eight cities, removed in other cities
Following a steady decline in daily COVID-19 cases, the Gujarat government on Thursday lifted night curfew in 19 cities and reduced curfew timings in eight major cities.
Chief Minister Bhupendra Patel took the decision after reviewing the situation at the state core committee meeting in Gandhinagar, an official release said. -PTI
Japan
Japan cures Pfizer COVID-19 oral pills amid rising infections
Japan has given fast-track approval to US drugmaker Pfizer Inc’s COVID-19 pill, the heath minister said on Thursday, as the country struggles to slow the fast-spreading Omicron infection.
Approval came less than a month after Pfizer went into effect in mid-January, an extraordinary pace in a country where foreign drug approvals typically take longer.
Health Minister Shigeyuki Goto said the availability of Pfizer’s Paxlovid pill gives more treatment options to high-risk patients, including elderly people and those with underlying health problems. -ap
,